Isolation and identification of phase I metabolites of resibufogenin in rats

References

• Arena JM, Drew RH. (1985). Poisoning: Toxicology, Symptoms, Treatments. 5th edition. Springfield, IL: Charles C. Thomas.
   Google Scholar
• Bick RJ, Poindexter BJ, Sweney RR, Dasgupta A. (2002). Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking. Life Sci 72:699–709.
   PubMed Web of Science ®Google Scholar
• Chen HR, Deng S, Chang P, Wang CY, Ma XC, Liu KX, Tian Y, Yao JH, Guo XY. (2012). Simultanous determination of resibufogenin and its major metabolite 3-epi-resibufogenin in rat plasma by HPLC coupled with tandem Mass Spectrometry. Chromatographia 75:103–109.
   Web of Science ®Google Scholar
• Cunha F, Resck GA, Cavalcanti IS, Pessoa BC, Moraes CO, Ferreira MO. (2010). Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion. Toxicon 56:339–348.
   Google Scholar
• Gilman A, Goodman LS, Rall TW, Murad F. (1985). The Pharmacological Basis of Therapeutics. 7th edition. New York: Macmillan.
   Google Scholar
• Kamano Y, Kotake A, Hashima H, Inoue M, Morita H, Takeya K, Itokawa H, Nandachi N, Segawa T, Yukita A, Saitou K, Katsuyama M, Pettit GR. (1998). Structure-cytotoxic activity relationship for the toad poison bufadienolides. Bioorg Med Chem 6:1103–1115.
   PubMed Web of Science ®Google Scholar
• Kamano Y, Yamashita A, Nogawa T, Morita H, Takeya K, Itokawa H, Segawa T, Yukita A, Saito K, Katsuyama M, Pettit GR. (2002). QSAR evaluation of the Ch’an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1). J Med Chem 45:5440–5447.
   PubMed Web of Science ®Google Scholar
• Li J, Ma X, Li F, Wang J, Chen H, Wang G, Lv X, Sun C, Jia J. (2010). Preparative separation and purification of bufadienolides from Chinese traditional medicine of ChanSu using high-speed counter-current chromatography. J Sep Sci 33:1325–1330.
   PubMed Web of Science ®Google Scholar
• Lee SS, Derguini F, Bruening RC, Nakanishi K, Wallick ET, Akizawa T, Rosenbaum CS, Butler VP. (1994). Digitalis-like compounds of toad bile: sulfation and reduction of bufadienolides decrease potency of Na+, K+-ATPase inhibition. Heterocycles 39:669–686.
   Google Scholar
• Lv X, Wang CY, Hou J, Zhang BJ, Deng S, Tian Y, Huang SS, Zhang HL, Shu XH, Zhen YH, Liu KX, Yao JH, Ma XC. (2012). Isolation and identification of metabolites of osthole in rats. Xenobiotica. DOI: 10.3109/00498254.2012.689887.
   Google Scholar
• Ma XC, Cui J, Zheng J, Guo DA. (2007a). Microbial transformation of three bufadienolides by Penicillum aurntigriseum and its application for metabolite identification in rats. J Mol Cat B: Enzymatic 48:42–50.
   Web of Science ®Google Scholar
• Ma XC, Zheng J, Guo DA. (2007b). Highly selective isomerization and dehydrogenation of three major bufadienolides at 3-OH by Fusarium solani. Enz Microb Technol 40:1585–1591.
   Web of Science ®Google Scholar
• Ma XC, Xin XL, Liu KX, Han J, Guo DA. (2008). Microbial transformation of cinobufagin by Syncephalastrum racemosum. J Nat Prod 71:1268–1270.
   PubMed Web of Science ®Google Scholar
• Ma XC, Zhang BJ, Xin XL, Huang SS, Deng S, Zhang HL, Shu XH, Diao YP, Cui J. (2009). Simultaneous quantification of seven major bufadienolides in three traditional Chinese medicinal preparations of chansu by HPLC-DAD. Nat Prod Commun 4:179–184.
   PubMed Web of Science ®Google Scholar
• Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, Chang DZ, Liao Z, Kurzrock R. (2009). Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 115:5309–5318.
   PubMed Web of Science ®Google Scholar
• Morishita S, Shoji M, Oguni Y, Ito C, Higuchi M, Sakanashi M. (1992). Pharmacological actions of “kyushin,” a drug containing toad venom: cardiotonic and arrhythmogenic effects, and excitatory effect on respiration. Am J Chin Med 20:245–256.
   PubMedGoogle Scholar
• National Commission of Chinese Pharmacopoeia. (2005). Pharmacopoeia of the People’s Republic of China. Beijing: Chemical Industry Press.
   Google Scholar
• Ning J, Wu TH, Tian Y, Wang CY, Tian G, Zhang BJ, Liu KX, Ma XC. (2010). Identification of cinobufagin metabolites in the bile of rats. Xenobiotica 40:48–54.
   PubMed Web of Science ®Google Scholar
• Nogawa T, Kamano Y, Yamashita A, Pettit GR. (2001). Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch’an Su. J Nat Prod 64:1148–1152.
   PubMed Web of Science ®Google Scholar
• Puschett JB, Agunanne E, Uddin MN. (2010). Marinobufagenin, resibufogenin and preeclampsia. Biochim Biophys Acta 1802:1246–1253.
   Google Scholar
• Qiu F, Zhu Z, Kang N, Piao S, Qin G, Yao X. (2008). Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metab Dispos 36:2159–2165.
   PubMed Web of Science ®Google Scholar
• Schoner W. (2002). Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269:2440–2448.
   PubMedGoogle Scholar
• Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. (1996). The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem 271:14067–14072.
   PubMed Web of Science ®Google Scholar
• Xin XL, Su DH, Sa D, Tian Y, Zhang BJ, Ma XC, An L, Huang SS, Yao JH, Cui X. (2011). Novel microbial transformation of resibufogenin by Fusarium solani. J Asian Nat Prod Res 13:831–837.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Luo X, Ming Y, Chen L, Li Y. (2006). Rapid separation and determination of resibufogenin and cinobufagin in toad venom and Liushen tablet by beta-cyclodextrin modified micellar electrokinetic chromatography. J Pharm Biomed Anal 41:124–128.
   Google Scholar